Top NYC, NY Biotech Companies (128)

OnCusp Therapeutics, Inc., headquartered in New York City, is a biopharmaceutical company dedicated to transforming cutting-edge preclinical innovation into clinically validated treatments for cancer patients worldwide. OnCusp was co-founded by Dr. Bing Yuan, Dr. Eric Slosberg, and Dr. Andy Fu, and has built a strong team of accomplished veterans with proven track records in building startup biotechs, leading successful preclinical...

Envisagenics was founded in 2014 as a spinout of Cold Spring Harbor Laboratory. Our mission is to reduce the complexity of biomedical data to accelerate the development of innovative therapeutic solutions through RNA splicing analytics and artificial intelligence. We focus on the discovery of RNA therapeutics. Over 30 million people in the US suffer from genetic diseases or cancer that...

Our vision is to eliminate errors in radiology and make the best diagnostic care available to everyone. We are an experienced team of clinicians, technologists, and industry professionals building state-of-the-art AI software to improve patient outcomes.

VantAI pairs bleeding-edge machine learning techniques with deep systems biology expertise to build computational models that uncover hidden relationships between molecules, targets, and diseases. These models power a best-in-class solution that identifies and generates new molecular entities for targets of interest, repurposes existing molecules at any stage of development, uncovers accurate ADME and toxicological insights, and predicts adverse events likely...

Our clinical trial solutions empower biopharma, medical device and CRO organizations to accelerate development. Contact us for trial management services.

The people of Memorial Sloan Kettering Cancer Center (MSK) are united by a singular mission: ending cancer for life. Our specialized care teams provide personalized, compassionate, expert care to patients of all ages. Informed by basic research done at our Sloan Kettering Institute, scientists across MSK collaborate to conduct innovative translational and clinical research that is driving a revolution in...

We develop frontier AI systems that identify biological threats and design medical countermeasures in real time. We're assembling exceptional people to join us in this mission. Our founding team comes from Palantir, DeepMind, the Broad Institute, and the Arc Institute, and we're actively hiring. We are grateful for the support of our investors including OpenAI, Lux Capital, Founders Fund, and more.

Astrix is the unrivaled market-leader in creating & delivering innovative strategies, solutions, and people to the life science community. Through world class people, process, and technology, Astrix works with clients to fundamentally improve business & scientific outcomes across many domains including the laboratory, clinical & regulatory, pharmacovigilance, R&D, and manufacturing. Founded by scientists to solve the unique challenges of the...

NovoPedics is a biotechnology company developing implantable meniscus replacement and regeneration medical devices.

Linus Biotechnology is a patient-centric, breakthrough science, precision exposome medicine company. Our program pipeline comprises precision exposome medicine biomarkers and target discovery across disease domains for which historically no molecular endpoints have been available in medical practice or for clinical trials, including CNS (autism spectrum disorder, amyotrophic lateral sclerosis), gastroenterology (inflammatory bowel disease), renal disease and oncology.

Since 2014, Vimachem has been transforming pharmaceutical and biotech manufacturing with the AI-powered, composable Vimachem Pharma MES Platform. Purpose-built for the Life Sciences industry, the platform has been deployed across 200+ pharma sites globally, helping manufacturers boost process efficiency, enhance product quality, and reduce compliance risk and lead times. Smart, flexible, and built with the pharma operator in mind, the Vimachem...

Ortho Clinical Diagnostics (Nasdaq: OCDX) is one of the world’s largest pure-play in vitro diagnostics (IVD) companies dedicated to transforming patient care. More than 800,000 patients across the world are impacted by Ortho’s tests each day. Because Every Test is a Life, Ortho provides hospitals, hospital networks, clinical laboratories and blood banks around the world with innovative technology and tools to...

INNOVERA™ is the transformative material crafted using plant- based proteins, biopolymers, and recycled rubber, resulting in over 80% renewable carbon content. Completely animal-free, INNOVERA™ is masterfully engineered to replicate the look and feel of the collagen found in leather. Developed by the bio-design company Modern Meadow (Nutley, New Jersey), INNOVERA™ redefines what’s possible across the automotive, footwear, furniture and fashion accessories spaces, creating high-performance products with a lower environmental...

Echo Therapeutics develops the Symphony tCGM System, a novel, non-invasive (needle-free) glucose monitoring system for diabetes patients.

Entoura is building an institutional scale & high quality and supply chain solution for Hemp, CBD Oil and Isolates. We have developed a multidisciplinary approach, bringing the best of genetic research, innovative farm practices, whole plant processing techniques, and manufacturing to produce the highest quality hemp derived cannabinoid products in a controlled supply chain environment, ensuring every stage, from seed...

We sequence proteins. Glyphic Biotechnologies is a biotechnology startup revolutionizing the field of proteomics. While DNA can reveal biological insights, proteins actually tell us what our bodies will do. We are developing a first-of-its-kind, next-generation protein sequencing platform to enable researchers to gain novel insights into biology and disease.

Output Biosciences is the world’s first preventative therapeutics company that extends human healthspan by combating chronic disease.

Cellectar Biosciences is a pharmaceutical research company specializing in cancer drugs.

Our goal is to enable the analysis of anything, anywhere, by anyone. We have developed the world’s first and only nanopore DNA and RNA sequencing platform. It’s a new generation of sequencing technology — the only one to offer: scalability to portable or ultra-high throughput formats, real-time data delivery, and the ability to elucidate rich biological data. We are aiming to disrupt...

Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes across oncology, neurology and cardiology. Headquartered in Massachusetts with offices in New Jersey, Canada, Germany, Sweden, Switzerland and the United Kingdom, Lantheus has been providing radiopharmaceutical solutions for 70 years.